He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tightly controlled. Click for my latest analysis of CCCC stock.

“When there is an attack that kills civilians or doesn’t hit its intended target, people are going to be asking, Oh, was that a human who made that mistake or was that an A.I. system?” By Kevin ...